Cargando…
Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report
BACKGROUND: Homozygous familial hypercholesterolaemia (FH) is an autosomal-dominant inherited disease presenting with highly elevated low-density lipoprotein cholesterol (LDL-C) levels. Untreated, the patient can develop atherosclerosis and cardiovascular disease already in adolescence. Treatment wi...
Autores principales: | Littmann, Karin, Szummer, Karolina, Hagström, Hannes, Dolapcsiev, Karoly, Brinck, Jonas, Eriksson, Mats |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047050/ https://www.ncbi.nlm.nih.gov/pubmed/32128483 http://dx.doi.org/10.1093/ehjcr/ytaa020 |
Ejemplares similares
-
A case report of an acute coronary syndrome in a 10-year-old boy with homozygous familial hypercholesterolaemia
por: Leclercq, Thibault, et al.
Publicado: (2020) -
Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report
por: Sjuls, Simon, et al.
Publicado: (2021) -
Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022) -
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
por: Blom, Dirk J., et al.
Publicado: (2018) -
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
por: Ben-Omran, Tawfeg, et al.
Publicado: (2019)